203 related articles for article (PubMed ID: 28911924)
21. In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
Breyer J; Wirtz RM; Otto W; Erben P; Kriegmair MC; Stoehr R; Eckstein M; Eidt S; Denzinger S; Burger M; Hartmann A;
Virchows Arch; 2017 Mar; 470(3):267-274. PubMed ID: 28074276
[TBL] [Abstract][Full Text] [Related]
22. Sialyl-Tn antigen as a useful predictor of poor prognosis in patients with advanced stomach cancer.
Terashima S; Takano Y; Ohori T; Kanno T; Kimura T; Motoki R; Kawaguchi T
Surg Today; 1998; 28(7):682-6. PubMed ID: 9697259
[TBL] [Abstract][Full Text] [Related]
23. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Dadhania V; Zhang M; Zhang L; Bondaruk J; Majewski T; Siefker-Radtke A; Guo CC; Dinney C; Cogdell DE; Zhang S; Lee S; Lee JG; Weinstein JN; Baggerly K; McConkey D; Czerniak B
EBioMedicine; 2016 Oct; 12():105-117. PubMed ID: 27612592
[TBL] [Abstract][Full Text] [Related]
24. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
[TBL] [Abstract][Full Text] [Related]
25. Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
Nicolazzo C; Busetto GM; Gradilone A; Sperduti I; Del Giudice F; Loreni F; Cortesi E; de Berardinis E; Gazzaniga P; Raimondi C
Oncologist; 2019 May; 24(5):612-616. PubMed ID: 30944184
[TBL] [Abstract][Full Text] [Related]
26. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.
Rebouissou S; Bernard-Pierrot I; de Reyniès A; Lepage ML; Krucker C; Chapeaublanc E; Hérault A; Kamoun A; Caillault A; Letouzé E; Elarouci N; Neuzillet Y; Denoux Y; Molinié V; Vordos D; Laplanche A; Maillé P; Soyeux P; Ofualuka K; Reyal F; Biton A; Sibony M; Paoletti X; Southgate J; Benhamou S; Lebret T; Allory Y; Radvanyi F
Sci Transl Med; 2014 Jul; 6(244):244ra91. PubMed ID: 25009231
[TBL] [Abstract][Full Text] [Related]
27. Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Ars E; Ríos J; Gázquez C; Villavicencio H; Alcaraz A
Urology; 2012 Jan; 79(1):240.e9-15. PubMed ID: 22055693
[TBL] [Abstract][Full Text] [Related]
28. Tn and Sialyl-Tn antigens in canine gastric tissues.
Flores AR; Lemos I; Rema A; Taulescu M; Seixas F; Reis CA; Gärtner F; Amorim I
Vet Comp Oncol; 2020 Dec; 18(4):615-625. PubMed ID: 32134186
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
Gazquez C; Ribal MJ; Marín-Aguilera M; Kayed H; Fernández PL; Mengual L; Alcaraz A
BJU Int; 2012 Nov; 110(9):1310-6. PubMed ID: 22416928
[TBL] [Abstract][Full Text] [Related]
30. Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer.
Dhawan D; Hahn NM; Ramos-Vara JA; Knapp DW
PLoS Genet; 2018 Aug; 14(8):e1007571. PubMed ID: 30089113
[TBL] [Abstract][Full Text] [Related]
31. Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder.
Masuda N; Murakami K; Kita Y; Hamada A; Kamada M; Teramoto Y; Sakatani T; Matsumoto K; Sano T; Saito R; Okuno Y; Ogawa O; Kobayashi T
Am J Pathol; 2020 Aug; 190(8):1752-1762. PubMed ID: 32339497
[TBL] [Abstract][Full Text] [Related]
32. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
Kobayashi K; Matsumoto H; Matsuyama H; Fujii N; Inoue R; Yamamoto Y; Nagao K
Oncol Rep; 2016 Nov; 36(5):2852-2860. PubMed ID: 27599396
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.
Imai J; Ghazizadeh M; Naito Z; Asano G
Anticancer Res; 2001; 21(2B):1327-34. PubMed ID: 11396208
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal relationship of Tn/NF-κB and sTn as an indicator of the prognosis of oral squamous cell carcinoma.
Lin CY; Ho JY; Hsieh MT; Chiang HL; Chuang JM; Whang-Peng J; Chang YC; Tseng YH; Chen SF; Nieh S; Hwang J
Histopathology; 2014 Apr; 64(5):713-21. PubMed ID: 24117943
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of HOX B13 expression in urinary bladder cancer progression.
Marra L; Cantile M; Scognamiglio G; Perdonà S; La Mantia E; Cerrone M; Gigantino V; Cillo C; Caraglia M; Pignata S; Facchini G; Botti G; Chieffi S; Chieffi P; Franco R
Curr Med Chem; 2013 Feb; 20(6):833-9. PubMed ID: 23276138
[TBL] [Abstract][Full Text] [Related]
37. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
[TBL] [Abstract][Full Text] [Related]
38. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer.
Polioudaki H; Agelaki S; Chiotaki R; Politaki E; Mavroudis D; Matikas A; Georgoulias V; Theodoropoulos PA
BMC Cancer; 2015 May; 15():399. PubMed ID: 25962645
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
[TBL] [Abstract][Full Text] [Related]
40. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]